Antonino Sottile
Papers
1
Total Citations
42
H-Index
1
About
Antonino Sottile is a leading urological researcher whose work focuses on improving the early detection and risk stratification of prostate cancer, particularly for men considering active surveillance. His major contributions center on the comparative evaluation of novel biomarkers and advanced imaging to predict clinically significant disease. In a landmark 2015 study, Sottile conducted the first in‑parallel comparison of multiparametric magnetic resonance imaging (mpMRI), the Prostate Health Index (PHI), and prostate cancer antigen 3 (PCA3) in men eligible for active surveillance. This work demonstrated that combining these tools significantly enhances the prediction of pathologically confirmed significant prostate cancer, offering a non‑invasive pathway to reduce unnecessary biopsies. With over 42 citations, this study has shaped clinical guidelines and sparked further research into multi‑modal risk assessment. Sottile’s contributions have been instrumental in moving the field toward precision diagnostics, helping clinicians better identify which patients truly require aggressive treatment versus those who can safely defer intervention. His research continues to influence urological practice and improve patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1